- Report
- October 2023
- 89 Pages
Egypt
From €3114EUR$3,500USD£2,702GBP
- Report
- October 2023
- 84 Pages
Canada
From €3114EUR$3,500USD£2,702GBP
- Report
- August 2023
- 75 Pages
Israel
From €3114EUR$3,500USD£2,702GBP
- Report
- October 2024
- 136 Pages
North America
From €3558EUR$4,000USD£3,088GBP
- Report
- September 2024
- 82 Pages
Japan
From €3114EUR$3,500USD£2,702GBP
- Report
- September 2023
- 83 Pages
Israel
From €3114EUR$3,500USD£2,702GBP
- Report
- August 2023
- 74 Pages
Canada
From €3114EUR$3,500USD£2,702GBP
- Report
- April 2023
- 117 Pages
Global
From €4226EUR$4,750USD£3,667GBP
- Report
- April 2023
- 129 Pages
Global
From €4226EUR$4,750USD£3,667GBP
- Report
- May 2024
- 130 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 137 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 131 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 132 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 133 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 135 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 139 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 133 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 133 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 138 Pages
Global
From €5781EUR$6,499USD£5,017GBP
- Report
- May 2024
- 140 Pages
Global
From €5781EUR$6,499USD£5,017GBP

Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon.
CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs.
The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more